Berenson, James B. External Entity

Publications

Sort by

Selected publications

  • Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma.  Cancer2005 Academic Article GET IT
    Times cited: 92
  • A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma.  British journal of haematology2004 Academic Article GET IT
    Times cited: 578